Bcl-2 expression in acute myeloblastic leukaemia: Relationship with autonomous growth and CD34 antigen expression

Leukemia and Lymphoma

Volumn 24, Issue 3-4, 1997, Pages 221-228

  Bradbury, D A ^a   Zhu, Y M ^b   Russell, N H ^b  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Acute myeloblastic leukaemia; Bcl 2; CD34

Indexed keywords

CD34 ANTIGEN; CYTOTOXIC AGENT; FLUOROCHROME; GROWTH FACTOR; PROTEIN BCL 2; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ACUTE MYELOBLASTIC LEUKEMIA; APOPTOSIS; BLAST CELL; CANCER GROWTH; CANCER SURVIVAL; CELL PROLIFERATION; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA REMISSION; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROGNOSIS; PROTO ONCOGENE; REVIEW;

EID: 0031040364     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199709039010     Document Type: Review

References (48)

1. Kerr, J. F. R , Wyllie, A. H. and Currie, A. R. (1972). Apoptosis. A basic biological phenomenon with wide-ranging implications in tissue kenetics, Br J Cancer, 26, 239-257.
2. Wyllie, A. H. (1980). Glucocorticoid-induced thymocyte apoptosis is associated with endogenous nuclease activity, Nature, 284, 555-556.
3. Williams, G. T., Smith, C. A., Spooncer, E., Dexter, T. M. and Taylor, D. R. (1990). Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis, Nature, 343, 76-79.
4. Rodriguez-Tarduchy, G., Collins, M. and Lopez-Rivas, A. (1990). Regulation of apoptosis in interleukin-3-dependent hemopoietic cells by interleukin-3 and calcium ionophores, EMBO J, 9, 2997-3002.
5. Tsujimoto, Y., Finger, L. R., Junis, J., Nowell, P. C and Croce, C. M. (1984). Cloning of the chromosome breakpoint of neoplastic B cells with the t(14:18) chromosomal translocation, Science, 226, 1097-1099.
6. Pezzella, F., Tse, A. G. D., Cordell, J. L., Pulford, K. A. F., Gatter, K. C. and Mason, D. Y. (1990). Expression of the bcl-2 oncogene protein is not specific for the t(14;18) chromosomal translocation, Am J Pathol 137, 225-232.
7. Zutter, M., Hockenbery, D., Silverman, G. A. and Korsmeyer, S. J. (1991). Immunolocalisation of the bcl-2 protein within haemopoietic neoplasms, Blood, 81, 3091-3096.
8. Hockenbery, D. M., Zutter, M., Hickey, W., Nahm, M. and Korsmeyer, S. J. (1991). bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death, PNAS USA, 88, 6961-6965.
9. Hockenbery, D., Nunez, G., Milliman, C., Schreiber, R. D. and Korsmeyer, S. J. (1990). bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death, Nature, 348, 334-336.
10. Chen-Levy, Z. and Clearly, M. L. (1990). Membrane topology of the bcl-2 proto-oncogene protein demonstrated in vivo, J Biol Chem, 265, 4929-4933.
11. Jacobson, M. D., Burnett, J. F., King, M. D., Miyashita, T., Reed, J. C. and Raff, M. C. (1993). Bcl-2 blocks apoptosis in cells lacking mitochondria, Nature, 361, 365-369.
12. Monaghan, P., Robertson, G., Amos, T. A S., Dyer, M. J. S., Mason, D. Y. and Graves, M. F. (1992). Ultrastructural localisation of bcl-2 protein, J Histochem Cytochem. 40, 1819-1825.
13. Boise, L H , Gonzalez-Garcia, M. and Postema, C. E. et al. (1993). bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death, Cell, 74, 597-608.
14. Oltvai, Z. N., Milliman, C. L., Korsmeyer, S. J. (1993). bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death, Cell, 74, 609-619.
15. Yin, X.-M , Oltvai, Z. N. and Korsmeyer, S. J. (1994). BH1 and BH2 domains of bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax, Nature, 369, 321-323
16. Korsmeyer, S. J., Shutter, J. R., Veis, D. J., Merry, D E. and Oltvai, Z N (1993) bcl-2/Bax: a rheostat that regulates an antioxidant pathway and cell death, Seminars in Cancer biology, 4, 327-332.
17. Delia, D., Aiello, A. and Soligo, D. et al. (1992). bcl-2 protooncogene expression in normal and neoplastic human myeloid cells. Blood, 79, 1291-1298.
18. Nunez, G., London, L , Hockenbery, D., Alexander, M., McKearn, J. P. and Korsmeyer, S. J. (1990). Dysregulated bcl- 2 gene expression selectively prolongs the survival of growth- factor deprived hemopoietic cell lines. J Immunol, 144, 3602-3610.
19. Vaux, D. L., Cory, S., Adams, J. M. (1988) bcl-2 gene promotes haemopoietic survival and cooperates with c-myc to immortalise pre-B-cells, Nature, 335, 440-446.
20. Bradbury, D. A., Russell, N. H. (1995). Comparative quantitative expression of bcl-2 by normal and leukaemic myeloid cells, Br J Haematol, 91, 374-379.
21. Porwitt-MacDonald, A., Ivory, K., Wilkinson, S., Wheatley, K , Wong, L., Janossy, G. (1995). bcl-2 protein expression in normal human bone marrow precursors and in acute myelogenous leukaemia, Leukaemia, 9, 1191-1198.
22. Park, J. R., Bernstein, I. D., Hockenbery, D. M. (1995). Primitive human haematopoietic precursors express bcl-x but not bcl-2, Blood, 86, 868-876.
23. Miyashita, T., Reed, J. C. (1993). bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukaemia cell line, Blood, 81, 151-157.
24. Campos, L., Sabido, O., Rouault, J.-P., Guyotat, D. (1994). Effects of bcl-2 antisense oligonucleotides on in vitro proliferation and survival of normal marrow progenitors and leukemic cells, Blood, 84, 595-600.
25. Keith, F. J., Bradbury, D. A., Zhu, Y -M., Russell, N. H. (1995). Inhibition of bcl-2 with antisense oligonucleotides induces apoptosis and increases the sensitivity of AML blasts to Ara-C, Leukaemia, 9, 131-138.
26. Campana, D., Coustan-Smith, E., Manabe, A. et al. (1993). Prolonged survival of B-lineage acute lymphoblastic leukaemia cells is accompanied by overexpression of bcl-2 protein, Blood, 81, 1025-1031.
27. Campos, L., Rouault, J.-P., Sabiolo, O. et al. (1993). High expression of bcl-2 protein in acute myeloid leukaemia cells is associated with poor response to chemotherapy, Blood, 81, 3091-3096.
28. Young, I. T. (1977). Proof without prejudice: use of the Kolmogorov-Smirnov test for the analysis of histograms from flow systems and other sources, J Histochem Cytochem, 25, 935-941.
29. Danescu, M., Rubio-Trujillo, M., Biron, G., Dron, D., Delespesse, M., Scarfati, M. (1992). Interleukin-4 protects chronic lymphocytic leukaemic B cells from death by apoptosis and upregulates bcl-2 expression, J Exp Med, 176, 1319-1325.
30. Rogers, S Y., Bradbury, D., Kozlowski, R., Russell, N. H. (1994). Evidence for internal autocrine regulation of growth in acute myeloblastic leukaemia cells, Exp Haematol, 22, 593-598.
31. Bradbury, D., Zhu, Y.-M , Russell, N. (1994). Regulation of bcl-2 expression and apoptosis in acute myeloblastic leukaemia cells by granulocyte-macrophage colony-stimulating factor, Leukaemia, 8, 786-791.
32. Reilly, I. A. G., Kozlowski, R., Russell, N. H. (1989). Heterogenous mechanisms of autocrine growth of AML blasts, Br J Haematol, 72, 363-369.
33. Lowenberg, B., van Potten, W. L. J., Touw, I., Dewel, R., Santini, V. (1992). Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult myeloid leukaemia. New Engl J Med, 328, 614-619.
34. Hunter, A. E., Rogers, S. Y., Reilly, I. A. G., Barrett, A. J., Russell, N. H. (1993). Autonomous growth of blast cels is associated with reduced survival in acute myeloblastic leukaemia, Blood, 82, 899-903.
35. Bradbury, D., Rogers, S., Reilly, I. A G., Kozlowski, R., Russell, N. H. (1992). Role of autocrine and paracrine production of granulocyte-macrophage colony-stimulating factor and interleukin-1β in the autonomous growth of acute myeloblastic leukaemia cells - studies using purified CD34-positive cells, Leukaemia, 6, 552-556.
36. Bradbury, D., Rogers, S., Kozlowski, R., Bowen, G., Reilly, I. A. G., Russell, N. H. (1990). Interleukin-1 is one factor which regulates autocrine production of GM-CSF by the blast cells of acute myeloblastic leukaemia, Br J Haematol, 76, 488-493.
37. Bradbury, D., Bowen, G., Kozlowski, R., Reilly, I. A. G., Russell, N. H. (1990). Endogenous interleukin-1 can regulate autonomous growth of acute myeloblastic leukaemia by inducing autocrine secretion of GM-CSF, Leukaemia, 4, 44-47.
38. Young, D. C., Griffin, J. D. (1986). Autocrine secretion of GM- CSF in acute myeloblastic leukaemia, Blood, 68, 1178-1181.
39. Geller, R. B., Zahurak, M., Hurwitz, C. A. et al. (1990) Prognostic importance of immunophenotyping in adults with acute myeloblastic leukaemia: the significance of stem cell glycoprotein CD34 (My 10), Br J Haematol, 76, 340-347.
40. Lee, E. J., Yang, J , Leavitt, R. D. et al (1992). The significance of CD34 and TdT determinations in patients with untreated de novo acute myeloid leukaemia, Leukaemia, 6, 1203-1209.
41. te Boekhorst, P. A. W., Lowenberg, B., Sonneveld, P. (1993). Enhanced chemosensitivity in acute myeloid leukaemia by haematopoietic growth factors: a comparison of the MTT assay with a clonogenic assay, Leukaemia, 7, 1637-1644.
42. Selleri, C., Notaro, R., Catalano, L., Fontana, R., Vecchio, L. D., Rotoli, B. (1992). Prognostic irrelevance of CD34 in acute myeloid leukaemia, Br J Haematol, 82, 479-480.
43. Ahuja, H., Bareli, M., Advani, S. H., Benchimol, S., Cline, M. J. (1989). Alteration in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukaemia, PNAS USA, 86, 6783-6787.
44. Holmes, J., Jacobs, A., Carter, G., Janowska-Weiczorek, A., Padua, R. (1989). Multidrug resistance in haemopoietic cell lines, myelodysplastic syndromes and acute myeloblastic leukaemia, Br J Haematol, 72, 40-44.
45. Lotem, J., Sachs, L. (1993). Regulation by bcl-2, c-myc and p53 of suseptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation competent and defective myeloid leukemic cells, Cell Growth Different, 4, 41-47.
46. Lotem, J., Sachs, L. (1992). Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor β1 and cancer chemotherapy compounds in myeloid leukemic cells, Blood, 80, 1750-1757.
47. Estey, E., Thall, P. F., Kantarjian, H. et al. (1992). Treatment of newly diagnosed acute myelogenous leukaemia with granulocyte-macrophage colony-stimulating factor (GM-CSF) before and during continuous infusion high-dose Ara-C and daunorubicm: comparison to patients treated without GM-CSF, Blood, 79, 2246-2255.
48. Hu, Z.-B., Minden, M. D., McCulloch, E. A. (1995). Direct evidence for the participation of bcl-2 in the regulation by retinoic acid of the Ara-C sensitivity of leukaemic stem cells, Leukaemia, 9, 1667-1673.